Personal Injury Lawyers
Menu
602.252.8888
800.883.8888
Injury Lawyers

Testosterone News

Jon O'Steen

Low-T Drug Therapy Lawsuits Grow in Number

Jonathan V. O'Steen
August 6, 2014

More than 150 lawsuits already have been filed against manufacturers of low testosterone therapy drugs in the U.S. District Court for the Northern District of Illinois. This is the court in which low-T drug litigation has been consolidated into what is called "multidistrict litigation (MDL)" in the federal court system.

Jon O'Steen

Attorney for Low-T Drug Patients Urges FDA to Prevent "Off Label" Use

Jonathan V. O'Steen
July 30, 2014

Phoenix attorney Jonathan O'Steen has asked the federal Food and Drug Administration (FDA) to take action to prevent off-label use of the testosterone therapy drugs AndroGel, AndroDerm, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim and Testopel.

Van O'Steen

Androgel Manufacturer Wants Coordination of Low-T Lawsuits

Van O'Steen
February 12, 2013

In June, all testosterone therapy lawsuits previously filed in various federal courts throughout the United States were consolidated in a single court—the U.S. District Court for the Northern District of Illinois. The advantages of consolidation include efficiency, resource conservation, reduction of duplication in the trial preparation process and elimination of the possibility of conflicting rulings among different courts.

The Law Firm You Choose Makes a Difference

In the largest injury case in the history of the world, we were selected as the only Arizona law firm to represent the State of Arizona against American tobacco companies for the past, present and future costs of treating tobacco-related illnesses. As a result, the State is expected to recover more than $3 billion. Accident Injury Lawyers